Clinically relevant vaccine-vaccine interactions - A guide for practitioners

被引:9
作者
Gizurarson, S [1 ]
机构
[1] Univ Iceland, Dept Pharm, IS-127 Reykjavik, Iceland
关键词
D O I
10.2165/00063030-199809060-00002
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
The need for combination vaccines has been recognised for many years. Many children must have 9 or 12 injections in their first year, which places a considerable burden on the child and the health service. Combination vaccines or simultaneously administered vaccines need to generate a protective immune response to all vaccine components that is equivalent to the response when administered separately. This is not always the situation. Many vaccines should not be administered together because of adverse reactions known as vaccine-vaccine interactions, a phenomenon where one vaccine affects another vaccine, thus potentially causing loss of immunogenicity, loss of protective efficacy or induction of adverse reactions. It is important to remember that most vaccine-vaccine interactions are asymptomatic and may only be discovered when the immune status of the vaccine recipient is analysed or when the individual is challenged by the microbe. The interactions may occur because of physical or chemical interactions within the vaccine formulation, interactions between live vaccines or immunological interference. This review summarises known vaccine-vaccine interactions that have been critically analysed and categorised based on their clinical importance.
引用
收藏
页码:443 / 453
页数:11
相关论文
共 70 条
[1]
Ajjan N, 1978, Dev Biol Stand, V41, P209
[2]
COMBINED VACCINATION AGAINST YELLOW-FEVER AND TYPHOID-FEVER - A COMPARATIVE TRIAL [J].
AMBROSCH, F ;
FRITZELL, B ;
GREGOR, J ;
JONAS, S ;
KOLLARITSCH, H ;
TEULIERES, L ;
WIEDERMANN, G .
VACCINE, 1994, 12 (07) :625-628
[3]
APRILE MA, 1966, C J PUBLIC HEALTH, V57, P343
[4]
ARBETER AM, 1986, PEDIATRICS, V78, P748
[5]
NEWBORN UNIVERSAL IMMUNIZATION AGAINST HEPATITIS-B - IMMUNOGENICITY AND REACTOGENICITY OF SIMULTANEOUS ADMINISTRATION OF DIPHTHERIA/TETANUS/PERTUSSIS (DTP) AND ORAL POLIO VACCINES WITH HEPATITIS-B VACCINE AT 0, 2 AND 6 MONTHS OF AGE [J].
ARISTEGUI, J ;
MUNIZ, J ;
LEGORBURU, AP ;
IMAZ, M ;
ARRATE, JP ;
SUAREZ, MD ;
GOIRI, MD .
VACCINE, 1995, 13 (11) :973-977
[6]
HAEMOPHILUS-INFLUENZAE TYPE-B POLYSACCHARIDE-TETANUS PROTEIN CONJUGATE VACCINE DOES NOT DEPRESS SEROLOGIC RESPONSES TO DIPHTHERIA, TETANUS OR PERTUSSIS ANTIGENS WHEN COADMINISTERED IN THE SAME SYRINGE WITH DIPHTHERIA-TETANUS-PERTUSSIS VACCINE AT 2, 4 AND 6 MONTHS OF AGE [J].
AVENDANO, A ;
FERRECCIO, C ;
LAGOS, R ;
HORWITZ, I ;
CAYAZZO, M ;
FRITZELL, B ;
MESCHIEVITZ, C ;
LEVINE, M .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1993, 12 (08) :638-643
[7]
IMMUNIZATION OF INFANTS AND YOUNG-CHILDREN WITH LIVE ATTENUATED TRIVALENT COLD-RECOMBINANT INFLUENZA-A H1N1, H3N2, AND INFLUENZA-B VACCINE [J].
BELSHE, RB ;
SWIERKOSZ, EM ;
ANDERSON, EL ;
NEWMAN, FK ;
NUGENT, SL ;
MAASSAB, HF .
JOURNAL OF INFECTIOUS DISEASES, 1992, 165 (04) :727-732
[8]
Bentley D W, 1992, Clin Geriatr Med, V8, P745
[9]
COMBINED LIVE MEASLES MUMPS AND RUBELLA VIRUS VACCINES [J].
BUYNAK, EB ;
WEIBEL, RE ;
WHITMAN, JE ;
STOKES, J ;
HILLEMAN, MR .
JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1969, 207 (12) :2259-&
[10]
SURVEILLANCE OF THE SAFETY OF SIMULTANEOUS ADMINISTRATION OF VACCINES - THE CENTERS-FOR-DISEASE-CONTROL AND PREVENTION EXPERIENCE [J].
CHEN, RT ;
HABER, P ;
MULLEN, JR .
COMBINED VACCINES AND SIMULTANEOUS ADMINISTRATION: CURRENT ISSUES AND PERSPECTIVES, 1995, 754 :309-320